Patent & IP news for January 9, 2017

Patent Litigations

USPTO Weekly Stats

6,755
published
appl'ns
6,505
granted
patents
64
ptab
decisions

Patent & IP Blogs

post image Watch out lawyers - do you own your name? from ipkitten.blogspot.com

That which we call a roseDo lawyers own goodwill in their name? The UK's IP Enterprise Court tells all in Bhayani & Anor v Taylor Bracewell LLP [2016] EWHC 3360.

This was a summary judgment ...

Share via E–mail | Twitter | Facebook

Top Five Stories of 2016 from www.patentdocs.org

By Donald Zuhn –- After reflecting upon the events of the past twelve months, Patent Docs presents its tenth annual list of top patent stories. For 2016, we identified twenty stories that were covered on Patent ...

Share via E–mail | Twitter | Facebook

Ignoring Nautilus: Sonix Tech. v. Publications Int’l from patentlyo.com

Sonix Tech. v. Publications Int’l (Fed. Cir. 2017) The district court awarded summary judgment to the defendant — finding the asserted claims invalid as indefinite under 35 U.S.C. § 112 ¶ 2.  On appeal, the ...

Share via E–mail | Twitter | Facebook

Book Review: A look At Antitrust Issues In Intellectual Property Law from www.ip-watch.org

The book Antitrust Issues in Intellectual Property Law, edited by Bradford Lyerla and authored by several lawyers, is about the intersection of IP law and antitrust law and collects case law from 2015 and 20152016 ...

Share via E–mail | Twitter | Facebook

Expensive Medicines Increase The Pressure from www.ip-watch.org

By Simon Schmid This article first appeared in the Neue Zürcher Zeitung, here. When Gilead brought its new antiviral medicine – Sovaldi – for the treatment of Hepatitis C to the US market for USD 84,000 ...

Share via E–mail | Twitter | Facebook

Eight Video Signal Transfer Patents Invalid Under 35 U.S.C. § 101 Despite Earlier PTAB Findings of Nonobviousness from docketreport.blogspot.com

The court granted defendant's motion to dismiss because the asserted claims of plaintiff’s video signal transfer patents encompassed unpatentable subject matter and rejected plaintiff's argument that the claims did not lack an ...

Share via E–mail | Twitter | Facebook

Opinion Counsel’s Involvement in Litigation Justifies Discovery of Communications with Trial Counsel from docketreport.blogspot.com

The court granted plaintiff's motion to compel discovery regarding communications between defendants' opinion and trial counsel because of opinion counsel's involvement in the present suit. "[B]y involving opinion counsel in the substantive ...

Share via E–mail | Twitter | Facebook

Why a strong patent system is vital from patentlyo.com

Prof. Dolin on Patents and Russia in the Washington Times: Last month was the 25th anniversary of the dissolution of the Soviet Union, marking the end of the Cold War. Just a few years earlier ...

Share via E–mail | Twitter | Facebook

Legal Guide for Bloggers from dunlapcodding.com

Douglas J. Sorocco

This is a reprise of a popular blog post published some years ago.

The EFF has released a Legal Guide for Bloggers. Included in this guide are sections on defamation, reporter's ...

Share via E–mail | Twitter | Facebook

The - Monica Crowley- copying matter from ipbiz.blogspot.com


A post at CNN begins:


Conservative author and television personality Monica Crowley, whom Donald Trump has tapped for a top national security communications role, plagiarized large sections of her 2012 book, a CNN KFile review ...

Share via E–mail | Twitter | Facebook

How is Teva's MS drug Copaxone doing from ipbiz.blogspot.com



Pantagraph talks about possible investor concerns over Teva/Copaxone:


For example, concerns over Copaxone are largely overstated. Teva Pharmaceutical was able to reformulate Copaxone into an extended-release medication that only needs to be taken three ...

Share via E–mail | Twitter | Facebook

Patentlyo Bits and Bytes by Anthony McCain from patentlyo.com

Peter Harter & Gene Quinn: Patent Forecast 2017: Will Patent Courts Be Great Again? Evan Schuman: A Potentially Fatal Blow Against Patent Trolls Donald Zuhn: Top Five Stories Of 2016 Matthew Herper: Could Amgen’s Patent ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2017 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.